Fujian Wanchen Biotechnology Co. Ltd (300972) - Total Assets
Based on the latest financial reports, Fujian Wanchen Biotechnology Co. Ltd (300972) holds total assets worth CN¥7.46 Billion CNY (≈ $1.09 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Fujian Wanchen Biotechnology Co. Ltd for net asset value and shareholders' equity analysis.
Fujian Wanchen Biotechnology Co. Ltd - Total Assets Trend (2019–2024)
This chart illustrates how Fujian Wanchen Biotechnology Co. Ltd's total assets have evolved over time, based on quarterly financial data.
Fujian Wanchen Biotechnology Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Fujian Wanchen Biotechnology Co. Ltd's total assets of CN¥7.46 Billion consist of 79.6% current assets and 20.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 32.8% |
| Accounts Receivable | CN¥18.47 Million | 0.3% |
| Inventory | CN¥2.14 Billion | 29.5% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥59.52 Million | 0.8% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Fujian Wanchen Biotechnology Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 300972 company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Fujian Wanchen Biotechnology Co. Ltd's current assets represent 79.6% of total assets in 2024, an increase from 11.3% in 2019.
- Cash Position: Cash and equivalents constituted 32.8% of total assets in 2024, up from 4.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 8.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 29.5% of total assets.
Fujian Wanchen Biotechnology Co. Ltd Competitors by Total Assets
Key competitors of Fujian Wanchen Biotechnology Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
New Hope Liuhe Co Ltd
SHE:000876
|
China | CN¥116.87 Billion |
|
Austevoll Seafood ASA
OL:AUSS
|
Norway | Nkr53.09 Billion |
|
SLC Agrícola S.A
SA:SLCE3
|
Brazil | R$21.34 Billion |
|
Sipef NV
BR:SIP
|
Belgium | €1.21 Billion |
|
Shandong Xiantan Co Ltd
SHE:002746
|
China | CN¥7.77 Billion |
|
Vital Farms Inc
NASDAQ:VITL
|
USA | $518.74 Million |
|
Henan Huaying Agricultural Development Co Ltd
SHE:002321
|
China | CN¥3.95 Billion |
|
Inghams Group Ltd
AU:ING
|
Australia | AU$2.36 Billion |
Fujian Wanchen Biotechnology Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.37 | 1.11 | 1.80 |
| Quick Ratio | 1.00 | 0.84 | 1.45 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.65 Billion | CN¥347.99 Million | CN¥131.10 Million |
Fujian Wanchen Biotechnology Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Fujian Wanchen Biotechnology Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 18.63 |
| Latest Market Cap to Assets Ratio | 0.88 |
| Asset Growth Rate (YoY) | 84.8% |
| Total Assets | CN¥7.25 Billion |
| Market Capitalization | $6.35 Billion USD |
Valuation Analysis
Near Book Valuation: The market values Fujian Wanchen Biotechnology Co. Ltd's assets close to their book value (0.88x), suggesting investors view the company's assets at approximately fair value.
Rapid Asset Growth: Fujian Wanchen Biotechnology Co. Ltd's assets grew by 84.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Fujian Wanchen Biotechnology Co. Ltd (2019–2024)
The table below shows the annual total assets of Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥7.25 Billion ≈ $1.06 Billion |
+84.78% |
| 2023-12-31 | CN¥3.93 Billion ≈ $574.40 Million |
+226.80% |
| 2022-12-31 | CN¥1.20 Billion ≈ $175.77 Million |
+39.15% |
| 2021-12-31 | CN¥863.18 Million ≈ $126.31 Million |
+31.06% |
| 2020-12-31 | CN¥658.59 Million ≈ $96.37 Million |
+0.45% |
| 2019-12-31 | CN¥655.63 Million ≈ $95.94 Million |
-- |
About Fujian Wanchen Biotechnology Co. Ltd
Fujian Wanchen Food Group Co., Ltd., together with its subsidiaries, engages in the research, development, cultivation, production, and sale of edible fungi in China and internationally. The company provides enoki and golden enoki, white jade, crab, seafood, deer antler, oyster, and other mushrooms products, as well as flammulina velutipes, hydrangea edulis, and pleurotus eryngii. It is also invo… Read more